Oct 25 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE PRESENTS POSITIVE RESULTS FROM TWO PHASE 1 CORAL
STUDIES, PROVIDING FURTHER PROOF-OF-CONCEPT FOR SELF-AMPLIFYING
MRNA (SAMRNA) IN INFECTIOUS DISEASES
* GRITSTONE BIO INC - INTERIM RESULTS FROM CORAL-CEPI SHOW
GOOD
TOLERABILITY AND IMMUNOGENICITY IN ALL VACCINE-NAÏVE SUBJECTS
DOSED
* GRITSTONE BIO INC - DATA PROVIDE FURTHER SUPPORT OF
GRITSTONE'S
SELF-AMPLIFYING MRNA (SAMRNA) AS PLATFORM FOR INFECTIOUS DISEASE
VACCINES
* GRITSTONE BIO INC - NEW DATA FROM CORAL-BOOST STUDY
DEMONSTRATE
BROAD AND DURABLE IMMUNE RESPONSE
Source text for Eikon: ID:nGNXc45LJD
Further company coverage: GRTS.O
((Reuters.Briefs@thomsonreuters.com;;))